Symdeko® (tezacaftor/ivacaftor)
for Cystic Fibrosis

Symdeko (ivacaftor/tezacaftor) is used to treat cystic fibrosis in patients aged 6 and older with a specific gene mutation. This combination therapy helps improve lung function, reduce the risk of infections, and support weight gain by enhancing the function of the CFTR protein.

Heart